{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:40:54Z","timestamp":1793284854129,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The inflammatory burden as measured by high-sensitivity C-reactive Protein (hsCRP) is recognized as a cardiovascular risk factor, which can however be affected by lifestyle-related risk factors (LRF). Up-to-date the interplay between hsCRP, LRF and presence and extent of atherosclerotic disease is still largely unknown, which we therefore sought to investigate in a contemporary population-based cohort. We included participants from the cross-sectional population-based\u00a0Hamburg City Health Study. Affected vascular beds were defined as coronary, peripheral, and cerebrovascular arteries. LRF considered were lack of physical activity, overweight, active smoking and poor adherence to a Mediterranean diet. We computed multivariable analyses with hsCRP as the dependent variable and LRF as covariates according to the number of vascular beds affected. In the 6765 individuals available for analysis, we found a stepwise increase of hsCRP concentration both according to the number of LRF present as well as the number of vascular beds affected. Adjusted regression analyses showed an independent association between increasing numbers of LRF with hsCRP levels across the extent of atherosclerosis. We demonstrate increasing hsCRP concentrations according to both the number of LRF as well as the extent of atherosclerosis, emphasizing the necessity of lifestyle-related risk factor optimization.<\/jats:p>","DOI":"10.1038\/s41598-023-48602-7","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:02:21Z","timestamp":1702047741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort study"],"prefix":"10.1038","volume":"13","author":[{"given":"Benjamin","family":"Bay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Blaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Bei der Kellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Waibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-A.","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Rimmele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goetz","family":"Thomalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Twerenbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Zyriax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian J.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Waldeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"22","key":"48602_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","volume":"37","author":"PM Ridker","year":"2016","unstructured":"Ridker, P. M. Residual inflammatory risk: Addressing the obverse side of the atherosclerosis prevention coin. Eur. Heart J. 37(22), 1720\u20131722 (2016).","journal-title":"Eur. Heart J."},{"issue":"12","key":"48602_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377(12), 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"48602_CR3","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381(26), 2497\u20132505 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"48602_CR4","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf, S. M. et al. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383(19), 1838\u20131847 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"48602_CR5","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker, P. M., Hennekens, C. H., Buring, J. E. & Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342(12), 836\u2013843 (2000).","journal-title":"N. Engl. J. Med."},{"issue":"9709","key":"48602_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Emerging Risk Factors Collaboration et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet. 375(9709), 132\u2013140 (2010).","journal-title":"Lancet."},{"issue":"10384","key":"48602_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker, P. M. et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: A collaborative analysis of three randomised trials. Lancet 401(10384), 1293\u20131301 (2023).","journal-title":"Lancet"},{"issue":"2","key":"48602_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2015.01.021","volume":"239","author":"P Rein","year":"2015","unstructured":"Rein, P. et al. Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease. Atherosclerosis 239(2), 299\u2013303 (2015).","journal-title":"Atherosclerosis"},{"key":"48602_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fimmu.2018.00430","volume":"9","author":"L Badimon","year":"2018","unstructured":"Badimon, L. et al. C-reactive protein in atherothrombosis and angiogenesis. Front. Immunol. 9, 430 (2018).","journal-title":"Front. Immunol."},{"issue":"6","key":"48602_CR10","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1371\/journal.pmed.0020160","volume":"2","author":"A Bakhru","year":"2005","unstructured":"Bakhru, A. & Erlinger, T. P. Smoking cessation and cardiovascular disease risk factors: Results from the third national health and nutrition examination survey. PLoS Med. 2(6), e160 (2005).","journal-title":"PLoS Med."},{"issue":"1","key":"48602_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2007.12.058","volume":"201","author":"YS Levitzky","year":"2008","unstructured":"Levitzky, Y. S. et al. Relation of smoking status to a panel of inflammatory markers: The framingham offspring. Atherosclerosis 201(1), 217\u2013224 (2008).","journal-title":"Atherosclerosis"},{"issue":"7","key":"48602_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1532-5415.2004.52307.x","volume":"52","author":"LH Colbert","year":"2004","unstructured":"Colbert, L. H. et al. Physical activity, exercise, and inflammatory markers in older adults: Findings from the health, aging and body composition study. J. Am. Geriatr. Soc. 52(7), 1098\u20131104 (2004).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"48602_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi, J., Joseph, L. & Pilote, L. Obesity and C-reactive protein in various populations: A systematic review and meta-analysis. Obes. Rev. 14(3), 232\u2013244 (2013).","journal-title":"Obes. Rev."},{"issue":"2","key":"48602_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/2047487319885458","volume":"28","author":"C Blaum","year":"2021","unstructured":"Blaum, C. et al. Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population. Eur. J. Prev. Cardiol. 28(2), 152\u2013158 (2021).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"22","key":"48602_CR15","doi-asserted-by":"publisher","first-page":"e023188","DOI":"10.1161\/JAHA.121.023188","volume":"10","author":"M Drozd","year":"2021","unstructured":"Drozd, M. et al. Causes of death in people with cardiovascular disease: A UK biobank cohort study. J. Am. Heart Assoc. 10(22), e023188 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"48602_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejvs.2023.01.002","volume":"65","author":"CA Behrendt","year":"2023","unstructured":"Behrendt, C. A. et al. Prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg city health study: A cross sectional analysis. Eur. J. Vasc. Endovasc. Surg. 65(4), 590\u2013598 (2023).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"5","key":"48602_CR17","doi-asserted-by":"publisher","first-page":"e12770","DOI":"10.1111\/jsr.12770","volume":"28","author":"I Fietze","year":"2019","unstructured":"Fietze, I. et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences-results of SHIP-Trend. J. Sleep Res. 28(5), e12770 (2019).","journal-title":"J. Sleep Res."},{"issue":"5","key":"48602_CR18","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","volume":"8","author":"P Song","year":"2020","unstructured":"Song, P. et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: A systematic review, meta-analysis, and modelling study. Lancet Glob. Health 8(5), e721\u2013e729 (2020).","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"48602_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","volume":"172","author":"C Diehm","year":"2004","unstructured":"Diehm, C. et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis 172(1), 95\u2013105 (2004).","journal-title":"Atherosclerosis"},{"issue":"6","key":"48602_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11739-011-0511-0","volume":"6","author":"C Cimminiello","year":"2011","unstructured":"Cimminiello, C. et al. The PANDORA study: Peripheral arterial disease in patients with non-high cardiovascular risk. Intern. Emerg. Med. 6(6), 509\u2013519 (2011).","journal-title":"Intern. Emerg. Med."},{"issue":"2","key":"48602_CR21","doi-asserted-by":"publisher","first-page":"e0211774","DOI":"10.1371\/journal.pone.0211774","volume":"14","author":"H Steppuhn","year":"2019","unstructured":"Steppuhn, H. et al. Individual and area-level determinants associated with C-reactive protein as a marker of cardiometabolic risk among adults: Results from the German national health interview and examination survey 2008\u20132011. PLoS One 14(2), e0211774 (2019).","journal-title":"PLoS One"},{"issue":"7","key":"48602_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-013-9819-6","volume":"28","author":"S Ahmadi-Abhari","year":"2013","unstructured":"Ahmadi-Abhari, S., Luben, R. N., Wareham, N. J. & Khaw, K. T. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: The EPIC-Norfolk study. Eur. J. Epidemiol. 28(7), 541\u2013550 (2013).","journal-title":"Eur. J. Epidemiol."},{"issue":"11","key":"48602_CR23","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41366-018-0309-5","volume":"43","author":"S L\u00f3pez-Dom\u00e8nech","year":"2019","unstructured":"L\u00f3pez-Dom\u00e8nech, S. et al. Dietary weight loss intervention improves subclinical atherosclerosis and oxidative stress markers in leukocytes of obese humans. Int. J. Obes. 43(11), 2200\u20132209 (2019).","journal-title":"Int. J. Obes."},{"issue":"1","key":"48602_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archinte.167.1.31","volume":"167","author":"E Selvin","year":"2007","unstructured":"Selvin, E., Paynter, N. P. & Erlinger, T. P. The effect of weight loss on C-reactive protein: A systematic review. Arch. Intern. Med. 167(1), 31\u201339 (2007).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"48602_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/oby.20072","volume":"21","author":"JM Nicklas","year":"2013","unstructured":"Nicklas, J. M. et al. Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: The randomized POUNDS LOST trial. Obesity (Silver Spring) 21(4), 681\u2013689 (2013).","journal-title":"Obesity (Silver Spring)"},{"issue":"34","key":"48602_CR26","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42(34), 3227\u20133337 (2021).","journal-title":"Eur. Heart J."},{"issue":"10","key":"48602_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","volume":"30","author":"DL Bhatt","year":"2009","unstructured":"Bhatt, D. L. et al. Prior polyvascular disease: Risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur. Heart J. 30(10), 1195\u20131202 (2009).","journal-title":"Eur. Heart J."},{"issue":"12","key":"48602_CR28","doi-asserted-by":"publisher","first-page":"e007385","DOI":"10.1161\/CIRCINTERVENTIONS.119.007385","volume":"12","author":"JA Gutierrez","year":"2019","unstructured":"Gutierrez, J. A., Aday, A. W., Patel, M. R. & Jones, W. S. Polyvascular disease: Reappraisal of the current clinical landscape. Circ. Cardiovasc. Interv. 12(12), e007385 (2019).","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"1","key":"48602_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2005.01.057","volume":"185","author":"D Kawanami","year":"2006","unstructured":"Kawanami, D. et al. C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis 185(1), 39\u201346 (2006).","journal-title":"Atherosclerosis"},{"issue":"2","key":"48602_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10654-019-00577-4","volume":"35","author":"A Jagodzinski","year":"2020","unstructured":"Jagodzinski, A. et al. Rationale and design of the Hamburg City health study. Eur. J. Epidemiol. 35(2), 169\u2013181 (2020).","journal-title":"Eur. J. Epidemiol."},{"issue":"7624","key":"48602_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Bmj 335(7624), 806\u2013808 (2007).","journal-title":"Bmj"},{"issue":"19","key":"48602_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N. Engl. J. Med. 385(19), 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med."},{"key":"48602_CR33","doi-asserted-by":"crossref","unstructured":"Touboul, P. J., Hennerici, M. G., Meairs, S., Adams, H., Amarenco, P., Bornstein, N. et al. Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis. 34(4), 290\u20136 (2012).","DOI":"10.1159\/000343145"},{"issue":"24","key":"48602_CR34","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","volume":"126","author":"V Aboyans","year":"2012","unstructured":"Aboyans, V. et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American heart association. Circulation 126(24), 2890\u20132909 (2012).","journal-title":"Circulation"},{"issue":"25","key":"48602_CR35","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/eurheartj\/ehw125","volume":"37","author":"RA Stewart","year":"2016","unstructured":"Stewart, R. A. et al. Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease. Eur. Heart J. 37(25), 1993\u20132001 (2016).","journal-title":"Eur. Heart J."},{"issue":"3","key":"48602_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. mice: Multivariate imputation by chained equations in R. J. Stat. Softw. 45(3), 1\u201367 (2011).","journal-title":"J. Stat. Softw."}],"updated-by":[{"DOI":"10.1038\/s41598-024-51444-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48602-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:05:26Z","timestamp":1704715526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48602-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48602-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-024-51444-6","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-51444-6","URL":"https:\/\/doi.org\/10.1038\/s41598-024-51444-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GT reports honoraria as consultant or lecturer from Acandis, Alexion, Amarin, Bayer, Boehringer Ingelheim, BristolMyersSquibb\/Pfizer, Daiichi Sankyo and Stryker, all outside of the submitted work. RT reports research support from the German Center for Cardiovascular Research (DZHK), the K\u00fchne Foundation, the Joachim Herz Foundation as well as speaker honoraria\/consulting honoraria from Abbott, Amgen, Astra Zeneca, Psyros, Roche, Siemens, Singulex and Thermo Scientific BRAHMS. RT is co-founder and shareholder of the ART-EMIS Hamburg GmbH, which holds an international patent application on the use of a computing device to estimate the probability of myocardial infarction (International Publication Numbers WO2022043229A1, TW202219980A).\u00a0SB has received research funding from Abbott Diagnostics, Bayer, SIEMENS, Singulex and Thermo Fisher. SB received honoraria for lectures from Abbott, Abbott Diagnostics, AstraZeneca, Bayer, AMGEN, Medtronic, Pfizer, Roche, SIEMENS Diagnostics, SIEMENS, Thermo Fisher and as member of Advisory Boards and for consulting for Bayer, Novartis and Thermo Fisher, all outside of the submitted work. FJB reports grants from Daiichi Sankyo, Pfizer, and Sanofi, non-financial support from Abbott, ASAHI INTECC, and Inari Medical, personal fees from Amgen and Novartis outside of the submitted work. CW reports lecture and consulting fees from AMGEN, Novartis, Daiichi Sankyo, Sanofi and AstraZeneca, all outside of the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21761"}}